Seeking Alpha

Medtronic's (MDT +0.2%) CoreValve heart implant increased 1-year survival rates amongst patients...

Medtronic's (MDT +0.2%) CoreValve heart implant increased 1-year survival rates amongst patients in a study and it improved their quality of life. Separately, a trial of the company's Symplicity renal denervation treatment helped reduce blood pressure in patients with "treatment-resistant hypertension," who have a high risk of "various cardiovascular events."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)